Advertisement
News
Subscribe to MDT Magazine News

Q2 profits surge for Edwards Lifesciences

July 25, 2013 4:31 pm | by Mass Device | Comments

Edwards Lifesciences posted surging 2nd-quarter profits on modest sales growth, saying sales of its flagship Sapien heart valve reached $90 million for the quarter. The Irvine, Calif.-based medical device company reported profits of $94.1 million, or 82¢ per share, on sales of $517.2 million for the 3 months ended June 30...

EnteroMedics Announces PMA Application for VBLOC Therapy in Obesity Accepted for Review and Filing by FDA

July 25, 2013 4:03 pm | by The Associated Press | Comments

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the U.S. FDA has accepted for filing the Company's Premarket Approval application for approval of the Maestro® Rechargeable System's VBLOC® vagal blocking therapy as a treatment for obesity.

TOPICS:

New Blood Clot Removal System Successfully Restores Blood Flow

July 25, 2013 3:47 pm | by Cardiovascular Institute of the South | Comments

Dr. Nick Cavros, interventional cardiologist with Cardiovascular Institute of the South (CIS) at Lafayette General Medical Center in Lafayette, Louisiana, used a new hand-held mechanical aspiration system to remove blood clots and increase blood flow.

TOPICS:
Advertisement

Officials Offer Update on Vermont Health Connect

July 25, 2013 2:45 pm | by Dave Gram, Associated Press | Comments

Three top Vermont officials expressed confidence Thursday that the state will be ready to launch the health insurance marketplace being set up under the federal Affordable Care Act on its scheduled startup date of Oct. 1.     

A Big Data Approach to Personalized Healthcare

July 25, 2013 2:26 pm | by Nitesh Chawla, University of Notre Dame | Comments

University of Notre Dame researchers have developed a computer-aided method that uses electronic medical records to offer the promise of rapid advances toward personalized health care, disease management and wellness.      

TOPICS:

Study in British Journal of Urology International Features a Practical Solution for MRI-Ultrasound Fusion to Enable Tumor-Targeted, Tissue-Preserving Prostate HIFU Treatment

July 25, 2013 2:16 pm | by The Associated Press | Comments

Study results published in the current issue of British Journal of Urology International (10.1111/bju.12223) demonstrate that new software to register and fuse information from magnetic resonance imaging (MRI) and ultrasound (US) images enables intraoperative visualization of tumors, not ordinarily seen in a US image.

TOPICS:

Invacare makes progress during 'most challenging year'

July 25, 2013 2:12 pm | by Mass Device | Comments

Ohio-based medical device maker Invacare (NYSE:IVC) jumped a few points today, despite posting a tough 2nd quarter, as the company reported progress in emerging from an FDA consent degree that has limited research, development and manufacturing abilities.

From Gold, a New Way to Control Blood Clotting

July 25, 2013 1:33 pm | by Anne Trafton, MIT | Comments

Using gold nanoparticles, MIT researchers have devised a new way to turn blood clotting on and off. The particles, which are controlled by infrared laser light, could help doctors control blood clotting in patients undergoing surgery, or promote wound healing.

TOPICS:
Advertisement

'Head-Mount Image Processing Unit' for Endoscopic Image Display

July 25, 2013 1:23 pm | by Sony Corporation | Comments

Sony Corporation has announced the launch of a head-mount image processing unit capable of receiving and outputting endoscope image signals, or controlling video images, which can then be displayed in 3D or 2D on an accompanying head-mounted monitor.

TOPICS:

Women’s Height Linked to Cancer Risk

July 25, 2013 1:00 pm | by AACR | Comments

The taller a postmenopausal woman is, the greater her risk for developing cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Height was linked to cancers of the breast, colon, endometrium, kidney, ovary, rectum, and thyroid, as well as to multiple myeloma and melanoma...  

TOPICS:

Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, Such as a Transdermal Patch

July 25, 2013 12:20 pm | by PR Newswire | Comments

Alliqua, Inc. (OTCQB: ALQA), a wound management and drug delivery company, is making strides to take advantage of the $142 billion drug delivery market by launching a preclinical proof-of-principal study of an experimental hydrogel transdermal patch containing lidocaine. 

TOPICS:

Second Sight eyes $10M funding round | Wall Street Beat

July 25, 2013 11:39 am | by Mass Device | Comments

Second Sight Medical is hoping to raise $10.5 million, according to a regulatory filing, as it brings its "bionic eye" Argus II retinal implant to the U.S. market. The device, comprised of an eyeglass-mounted camera and an electrical stimulator implanted in the eye, works by converting video images captured by a miniature camera housed in the patient's glasses...

TOPICS:

Johnson & Johnson subsidiary gets Class I recall for implantable infusion pumps

July 25, 2013 11:29 am | by Mass Device | Comments

The FDA puts its highest-risk label on a recall of programmable infusion pumps made by Codman & Shurtleff Inc., a division of Johnson & Johnson subsidiary DePuy Orthopaedics. Codman's implanted MedStream pumps were recalled over a potential defect in a component that measures the contents of the pump reservoir.

TOPICS:

Clinical Trial Completed on New Two-Part Heart Valve

July 25, 2013 11:08 am | by ValveXchange | Comments

Surgeons in Europe have completed clinical trials on the world’s first serviceable bioprosthetic heart valve, paving the way for the CE mark and commercial sale of an advanced heart valve that eliminates many common problems for cardiac valve patients.

TOPICS:

Tattoo Biosensor Warns When Athletes Are About to 'Hit the Wall'

July 25, 2013 10:54 am | by American Chemical Society | Comments

A new biosensor, applied to the human skin like a temporary tattoo, can alert marathoners, competitive bikers and other “extreme” athletes that they’re about to “bonk,” or “hit the wall,” scientists are reporting.       

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading